Skip to main content
Signal8

Scorpius Holdings, Inc. (SCPX)

Sector: Biotechnology

Industry: Biotechnology

Scorpius Holdings, Inc. logo

Scorpius Holdings, Inc.

OTC:SCPXHealthcare
$0.0002
CLOSED
Mkt Cap$2K
EV-
Float-
O/S12.39M
VOL9K sh
$ Vol$2
RVOL1.02×
Inst Own-
Net Cash/Sh-
Dilution
Historical Data
DateOpenHighLowCloseVolume
Nov 16, 20260.00010.00020.00010.00028,645
Nov 11, 20260.00160.00160.00020.0002200
Nov 10, 20260.00020.00020.00020.00021,334
Nov 9, 20260.00020.00100.00020.00021,221
Nov 6, 20260.00020.00020.00020.00025,290
Nov 5, 20260.00010.00010.00010.000119,798
Oct 29, 20260.00060.00060.00060.0006814
Oct 27, 20260.00060.00060.00060.000638,437
Oct 19, 20260.00010.00010.00010.0001218
Oct 14, 20260.00010.00010.00010.000115,466
Oct 12, 20260.00020.00020.00020.00021,437
Oct 9, 20260.00020.00020.00020.00021,006
Oct 8, 20260.00020.00020.00020.0002200
Oct 7, 20260.00050.00050.00020.00026,000
Oct 6, 20260.00050.00050.00050.00053,510
Oct 2, 20260.00050.00050.00050.0005100
Analyst Coverage
Analyst Coverage
ConsensusHold
Price Target
Not available
Ratings Distribution
BUY
0
HOLD
2
SELL
0
TOTAL2
Insider Trades
No insider transactions for this companyForeign private issuers and non-reporting entities don't file Form 4/5.
Shareholders
0.0%
Institutional
(0)
0.0%
Insiderⓘ
(0)
2.8%
5%+ Owners
(2)
of which 2.8% rests on schedules older than 24 months (2 holders)
97.2%
Unattributed (incl. retail)ⓘ
5%+ Beneficial2.8%
Unattributed (incl. retail)97.2%
Top Shareholders
NameShares%
3i, LP logo
3i, LP
· filed Feb 2026
0+6.8M via derivatives9.9% as filed
Ramnarain Joseph Jaigobind logo
Ramnarain Joseph Jaigobind
· may incl. warrants· stale · filed Sep 2024
309.0K2.5%
Jeffrey Wolf logo
Jeffrey Wolf
· may incl. warrants· stale · filed May 2024
33.2K0.3%
Sources: 13D/13GO/S: 12.4M · checked 8 Oct 2026 · market-data provider
About

Scorpius Holdings, Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization.

The company engages in clinical and commercial drug substance manufacturing; and release and stability testing activities.

It is also involved in the provision of various process development services, including upstream and downstream development and optimization, and analytical method development solutions, as well as cell line development, testing, and characterization services.

The company serves the biotechnology and biopharmaceutical industries.

The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024. Scorpius Holdings, Inc. was incorporated in 2008 and is based in San Antonio, Texas.

Key Metrics
Market Cap$2,478
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership-

No 13F filer reports a position yet. 13F reports are quarterly and are filed up to 45 days after the quarter ends.

SectorHealthcare
IndustryMedical - Pharmaceuticals
ExchangeOTC
CountryUSUS
IPO DateJul 24, 2013
Shares Outstanding12.39M
Authorized Shares
Float--
52-Week Range
$0.0001$0.1000
$0.0002(0th percentile)
Volume
Average Daily Volume8.44K
8.64K today vs 8.44K avg(+2%)

30d Avg

8.44K

60d Avg

20.14K

90d Avg

13.44K

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...

Scorpius Holdings, Inc. (OTC: SCPX) traded at $0.0002 on Nov 16, 2026. 52-week range: $0.0001 to $0.1000. The company is in the Healthcare sector (Medical - Pharmaceuticals).